2,973 followers
RT @FrontDrugDDS: New Research: ASK120067 (limertinib) exerts pre-clinical anti-tumor activity by inhibiting EGFR exon20 insertion https://…
RT @FrontDrugDDS: New Research: ASK120067 (limertinib) exerts pre-clinical anti-tumor activity by inhibiting EGFR exon20 insertion https://…
New Research: ASK120067 (limertinib) exerts pre-clinical anti-tumor activity by inhibiting EGFR exon20 insertion https://t.co/DkdQtb7Cdh #DrugDiscovery